Cardiol Therapeutics (CRDL.TO) Q4 2025 Earnings

18NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-0.19
-0.16
-0.13
-0.1

Details

Expected EPS
-0.10004164076418001
Actual EPS
-0.12049217520000001
Surprise EPS
-0.02
Surprise Percent
+20.44%

Description

Cardiol Therapeutics (CRDL.TO) has reported earnings of -0.12049217520000001 per share for Q4 2025.

0 Comments

Share your thoughts